Zajic P, Amrein K
Division of General Anesthesiology, Department of Anesthesiology and Intensive Care Medicine, Emergency Medicine and Intensive Care Medicine, Medical University of Graz, Graz, Austria -
Minerva Endocrinol. 2014 Dec;39(4):275-87. Epub 2014 Jul 29.
In the last decade, few substances have been discussed as controversially as vitamin D. In the last few years, vitamin D research has now also found its way into the intensive care unit (ICU). Vitamin D deficiency is commonly found in the ICU and is associated with adverse outcomes including excess mortality, longer length of stay, higher sepsis incidence, longer mechanical ventilation. But how should one single vitamin be capable of such an impact? It has to be kept in mind that vitamin D is not a classic vitamin at all. It can be synthesized in sufficient amounts by the human body, it has a nuclear receptor and a large number of genes are under direct or indirect control of vitamin D. Furthermore, both the vitamin D receptor and the 1-α hydroxylase which is required to activate vitamin D are widely distributed in the human body. Unfortunately, as in other settings, a large body of observational data is opposed to only a few intervention studies. This article seeks to review the current observational and interventional literature concerning vitamin D status in the context of critical care, its effects on this highly vulnerable population and possible treatment strategies as well as an outlook on research that is necessary in the future.
在过去十年里,很少有物质像维生素D这样备受争议。在过去几年中,维生素D研究如今也进入了重症监护病房(ICU)。ICU中普遍存在维生素D缺乏的情况,且它与包括死亡率过高、住院时间延长、脓毒症发病率升高、机械通气时间延长等不良后果相关。但单一一种维生素怎么会有如此大的影响呢?必须记住,维生素D根本不是一种典型的维生素。人体能够合成足够量的维生素D,它有一个核受体,大量基因受维生素D直接或间接控制。此外,维生素D受体以及激活维生素D所需的1-α羟化酶在人体中广泛分布。遗憾的是,与其他情况一样,大量的观察性数据与仅有少数的干预性研究相悖。本文旨在综述当前关于重症监护中维生素D状态的观察性和干预性文献、其对这一高度脆弱人群的影响、可能的治疗策略以及对未来所需研究的展望。